{"id":314,"date":"2021-02-10T10:05:00","date_gmt":"2021-02-10T18:05:00","guid":{"rendered":"https:\/\/caam.tech\/?p=314"},"modified":"2021-02-09T18:57:04","modified_gmt":"2021-02-10T02:57:04","slug":"patent-combining-psychedelics-with-cannabinoids-allowed-by-uspto","status":"publish","type":"post","link":"https:\/\/caam.tech\/patent-combining-psychedelics-with-cannabinoids-allowed-by-uspto\/","title":{"rendered":"Patent Combining Psychedelics with Cannabinoids Allowed by USPTO"},"content":{"rendered":"\n

ISSAQUAH, WA – February 10, 2021 – CaaMTech<\/a>, Inc., announced today that its first patent application, \u201cCompositions and methods comprising a psilocybin derivative\u201c (US20180221396A1), has been allowed by the US Patent and Trademark Office (USPTO). The notice of allowance is a watershed moment for CaaMTech\u2019s intellectual property division, which has filed in excess of one hundred additional patent applications since the application was filed in 2017.  Allowance is the final hurdle of examination before a patent is issued.<\/p>\n\n\n\n

\u201cThe allowance of our first patent application has given a shot of energy to the team that has worked diligently over these past four years to bring it to the finish line,\u201d said CaaMTech founder and CEO, Dr. Andrew Chadeayne<\/a>, \u201cWith hundreds of applications still to prosecute, this is a great start.\u201d<\/p>\n\n\n\n

Scientific research-backed intellectual property has always been in CaaMTech\u2019s DNA: after completing his PhD in Chemistry at Cornell University, Dr. Chadeayne began his professional career with Finnegan, Henderson, Farabow, Garrett & Dunner, where he worked on chemical and pharmaceutical patent law. More recently, Dr. Chadeayne built ebbu\u2019s intellectual property portfolio, which was pivotal in the startup company\u2019s success leading to an acquisition by cannabis giant, Canopy Growth Corporation.<\/p>\n\n\n\n

\u201cOur goal from Day 1 has been to capture as much as much of CaaMTech\u2019s scientific innovation as possible in our intellectual property portfolio as we develop the next-generation of psychedelic drugs,\u201d said Dr. Chadeayne, \u201cStrong patent protection and fundamental research give our drugs the foundational support that they need to proceed through clinical trials and become FDA-approved medicines.\u201d<\/p>\n\n\n\n

\u201cCompositions and methods comprising a psilocybin derivative\u201c covers (among other subject matter) the synergistic modulatory effects of cannabinoids on the activation of serotonin receptors when administered in conjunction with a serotonin agonist.  In simpler terms, CaaMTech has shown that cannabinoids work synergistically with psychedelic tryptamines in producing their effects. In doing so, CaaMTech has demonstrated the potential for two drugs once declared by the United States Federal Government to have \u201cno known medical value\u201d to treat some of the world\u2019s most challenging mental health issues.<\/p>\n","protected":false},"excerpt":{"rendered":"

CaaMTech\u2019s first of over one hundred patent applications is nearing the finish line<\/p>\n","protected":false},"author":1,"featured_media":80,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/posts\/314"}],"collection":[{"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/comments?post=314"}],"version-history":[{"count":0,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/posts\/314\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/media\/80"}],"wp:attachment":[{"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/media?parent=314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/categories?post=314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/caam.tech\/wp-json\/wp\/v2\/tags?post=314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}